Alcohol-induced flushing is a risk factor for esophageal cancer from alcohol consumption

March 23, 2009

Press release from PLoS Medicine

There is growing evidence, say researchers in this week's PLoS Medicine, that people who experience facial flushing after drinking alcohol are at much higher risk of esophageal cancer from alcohol consumption than those who do not.

About a third of East Asians (Japanese, Chinese, and Koreans) show a characteristic physiological response to drinking alcohol that includes facial flushing, nausea, and an increased heart rate. This so-called "alcohol flushing response" is predominantly due to an inherited deficiency in an enzyme called aldehyde dehydrogenase 2 (ALDH2). Although clinicians and the East Asian public generally know about the alcohol flushing response, few are aware of the accumulating evidence that ALDH2-deficient individuals are at much higher risk of esophageal cancer (specifically squamous cell carcinoma) from alcohol consumption than individuals with fully active ALDH2.

Dr Philip Brooks and colleagues from the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Maryland, USA, along with Dr. Akira Yokoyama from the Kurihama Alcohol Center in Japan, say that this lack of awareness is "unfortunate as esophageal cancer is one of the deadliest cancers worldwide, with five-year survival rates of 15.6% in the United States, 12.3% in Europe, and 31.6% in Japan."

"Our goal in writing this article," say the researchers, "is to inform doctors firstly that their ALDH2- deficient patients have an increased risk for esophageal cancer if they drink moderate amounts of alcohol, and secondly that the alcohol flushing response is a biomarker for ALDH2 deficiency."

Clinicians, they say, can determine ALDH2 deficiency simply by asking about previous episodes of alcohol-induced flushing.

"As a result," say Dr Brooks and colleagues, "ALDH2-deficient patients can then be counseled to reduce alcohol consumption, and high-risk patients can be assessed for endoscopic cancer screening."

In view of the approximately 540 million ALDH2-deficient individuals in the world, many of whom now live in Western societies, even a small percent reduction in esophageal cancers due to a reduction in alcohol drinking would translate into a substantial number of lives saved.

Public Library of Science

---

---

	100 Questions & Answers About Esophageal Cancer, 2nd Edition by Pamela K. Ginex (Author), Maureen Jingeleski (Author), Bart L. Frazzitta (Author), Manjit S. Bains (Author) The only reference to provide both the patient s and doctor s views, 100 Questions & Answers About Esophageal Cancer, Second Edition aims to provide a much needed primer for patients and their families and aims to address the questions most relevant to patients following a diagnosis of esophageal cancer. This text gives up-to-date, authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by two oncology nurses and a gastric surgeon, with extensive commentary from an esophageal cancer survivor, and new information on cancer therapies, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.
	Esophageal Cancer: Principles and Practice by Blair Jobe MD (Author), Thomas Charles MD (Author), Dr. John Hunter MD (Author) Gastroesophageal cancers are the most common form of cancer incidents, and the second most common cause of death among cancer patients. In 2000, it was estimated that over one million new cases of gastroesophageal cancers were diagnosed worldwide, and over 900,000 individuals died from the disease. Using a multi-disciplinary approach, Esophageal Cancer: Principles and Practice addresses the complexities encountered in the understanding and management of esophageal cancers. Written by the world s leading experts in surgery, medical oncology, radiation oncology, gastroenterology, pathology, radiology, nutrition, nurse specialists, palliative medicine, and research relating to neoplasia of the esophagus, this text will serve as the definitive resource and enable practitioners to provide the...
	John Hopkins Patients' Guide to Cancer of the Stomach and Esophagus (Johns Hopkins Medicine) by Mark D. Duncan (Author) Johns Hopkins Patients' Guide to Cancer of the Stomach and Esophagus is a concise, easy-to-follow how to guide that puts you on a path to wellness by explaining stomach and liver cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in everyday terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	Journeys through Cancer and Faith by United Writers Press The parallel journeys of two men who faced the diagnosis of esophageal cancer and found their own unique paths to a strengthened faith. In two different styles, Ed (Stage 2) and Bill (Stage 4) relate their individual stories, including how they met in an online support group and became friends. Honest, practical, and inspirational for those living with cancer and those who love them.
	100 Questions & Answers About Esophageal Cancer by Pamela K. Ginex (Author), Manjit S. Bains (Author), Jacqueline Hanson (Author), Bart L. Frazzitta (Author) This book gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by three esophageal cancer experts and an actual patient.
	Esophageal Cancer: Current and Emerging Trends in Detection and Treatment (Cancer and Modern Science) by Janey Levy (Author)
	Treatment of Esophageal and Hypopharingeal Squamous Cell Carcinoma (Updates in Surgery) by Giovanni De Manzoni (Editor) Squamous cell carcinoma of the esophagus has a lower incidence than other gastrointestinal tract cancer; however, there are many difficult issued related to the choice of appropriate therapy for these patients. In recent years, the use of multimodal treatment has greatly improved the prognosis of patients affected by this disease but several aspects of the oncological and surgical management are still controversial. This book aims to give a homogeneous approach to esophageal cancer treatment, based on the author’s lifetime experience in conjunction with exhaustive review of recent literature. In each chapter surgeons and oncologists will find appropriate tools for correct management of the diagnosis and therapy of this difficult disease. The book analyzes all the aspects of staging and...
	Esophageal Stents for the Treatment of Malignant Dysphagia in Patients with Esophageal Cancer (Postgraduate Medicine) by JTE Multimedia Abstract: Self-expanding metal stents (SEMS) are the current standard for relief of malignant esophageal dysphagia. Self-expanding plastic stents (SEPS) are also used for relief of malignant esophageal dysphagia and as neoadjuvant therapy due to their relative ease of removability. The innovations in design of both SEMS and SEPS have made their use more prevalent in patients with malignant dysphagia. We review the current literature on esophageal stents, including general concepts, indications, contraindications, SEMS and SEPS models, complications and their management, implications of tumor location, cost-effectiveness of stents in comparison with other modalities, and quality of life after stent placement.
	Current State of Endoscopic Therapies in Barrett's Esophagus and Esophageal Cancer (DOI: 10.3810/hp.2011.02.388) (Postgraduate Medicine) by JTE Multimedia Barrett’s esophagus (BE) is a premalignant condition that predisposes patients to esophageal adenocarcinoma. This risk increases with increasing dysplasia, especially in patients with BE and high-grade dysplasia. Radical esophagectomy had long been the only option for these patients; however, it has been associated with significant morbidity and mortality. Endoscopic therapies have been increasingly used as an alternative to radical esophagectomy given the minimally invasive nature and tolerability of the procedure relative to surgery. Currently, the most widely used endoscopic therapies include endoscopic mucosal resection, photodynamic therapy, CryoSpray ablation, and radiofrequency ablation. Retrospective and prospective studies on the use of each of these modalities in patients with...
	Esophagectomy Post Surgical Guide: Questions and Answers by Esophageal Cancer Education Foundation (Author) THE ESOPHAGEAL CANCER EDUCATION FOUNDATION The Esophageal Cancer Education Foundation (ECEF) www.fightec.org was formed in 2003 by Bart and Virginia Frazzitta. The initial purpose in establishing this 501 C 3 non-profit Organization was to help solicit funds for a CD ROM Project they had committed to fund for Memorial Sloan-Kettering Cancer Center. The project had a cost of $75,000. This was achieved and it served as the beginning of this Foundation geared to focus on a mission statement that covered three goals, namely: • To bring awareness and educate the public and medical community about this disease • To walk the journey with caregivers and with patients who have this disease • To support research projects that will lead to a test for early detection of this disease and...